Ensuring Optimal Clinical Benefit From Oral SERD Therapy in Patients With HR+/HER2- Breast Cancer

Get up to date on the use of oral selective estrogen receptor degraders (SERDs) for the management of HR-positive/HER2-negative metastatic breast cancer through downloadable slides from a live webinar, expert-led interactive case challenges, commentaries, podcasts, and a downloadable PDF to use when counseling patients on oral SERD therapy.

Share

Program Content

No activities added yet

Activities

Oral SERD Adherence HR+/HER2- Breast Cancer
The Pharmacist’s Role in Improving Medication Adherence to Oral SERD Therapy in HR+/HER2- Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2024

Expires: February 22, 2025

Activities

SERDs in BC
Ensuring Optimal Clinical Benefit From Oral SERD Therapy in Patients With HR+/HER2- Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2024

Expires: February 22, 2025

Activities

Oral SERD AEs
Side Effects of Oral SERD Therapy: What to Expect and When to Call Your Doctor
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 21, 2024

Faculty

cover img faculity

Manali Bhave, MD

Phase I Medical Director
Assistant Professor
Department of Hematology & Medical Oncology
Winship Cancer Institute
Emory University
Atlanta, Georgia

cover img faculity

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
UK Healthcare
Lexington, Kentucky

cover img faculity

Jamie L. Carroll, CNP, APRN, MSN

Assistant Professor of Medical Oncology
Mayo Clinic
Rochester, Minnesota

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with Practicing Clinicians Exchange and ProCE, LLC.

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner